UTAH MEDICAL PRODUCTS INC Income Statement
UTMD|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
UTAH MEDICAL PRODUCTS INC reported $50M in revenue and $17M in net income for FY2025. Revenue has grown at a 4.8% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.2M | $52.3M | $49.1M | $10.9M | $46.9M | $42.0M | $41.4M | $39.3M | $40.2M | $41.3M | $40.5M | $41.6M | $37.9M | $25.1M | $25.9M |
| Cost of Revenue | $20.2M | $20.1M | $18.1M | $16.6M | $17.4M | $15.7M | $15.0M | $15.6M | $16.0M | $16.3M | $16.2M | $16.2M | $15.5M | $11.9M | $12.1M |
| Gross Profit | $30.0M | $32.2M | $30.9M | $6.8M | $29.5M | $26.3M | $26.4M | $23.7M | $24.2M | $25.0M | $24.3M | $25.3M | $22.4M | $13.2M | $13.8M |
| SG&A Expense | $11.0M | $10.4M | $10.1M | $9.8M | $9.6M | $5.4M | $5.4M | $5.4M | $5.8M | $6.1M | $6.2M | $6.8M | -$7.2M | $2.4M | $2.4M |
| R&D Expense | $560.0K | $493.0K | $526.0K | $486.0K | $483.0K | $454.0K | $447.0K | $475.0K | $522.0K | $460.0K | $491.0K | $563.0K | -$518.0K | $397.0K | $361.0K |
| Operating Income | $16.8M | $19.8M | $18.9M | $13.7M | $17.6M | $18.7M | $19.0M | $16.2M | $15.7M | $16.2M | $14.8M | $15.2M | $11.8M | $8.9M | $9.4M |
| Interest Expense | - | - | - | - | - | - | - | - | $65.0K | $289.0K | $438.0K | $652.0K | $859.0K | $25.0K | $51.0K |
| Income Tax | $3.5M | $4.2M | $4.3M | $3.0M | $3.2M | $904.0K | $10.6M | $4.3M | $3.7M | $4.4M | $3.1M | $4.4M | $3.7M | $3.0M | $3.3M |
| Net Income | $16.6M | $16.5M | $14.8M | $3.1M | $14.7M | $18.6M | $8.5M | $12.1M | $11.8M | $11.4M | $11.4M | $10.2M | $7.4M | $6.0M | $6.3M |
| EPS (Basic) | $4.58 | $4.53 | $4.05 | $2.95 | $3.96 | $4.97 | $2.29 | $3.23 | $3.16 | $3.04 | $3.06 | $2.77 | $2.04 | $1.66 | $1.73 |
| EPS (Diluted) | $4.57 | $4.52 | $4.04 | $0.84 | $3.94 | $4.95 | $2.28 | $3.22 | $3.14 | $3.02 | $3.02 | $2.74 | $2.03 | $1.65 | $1.72 |
| Shares Outstanding | 3.3M | 3.6M | 3.6M | 3.7M | 3.6M | 3.7M | 3.7K | 3.7K | 3.7M | 3.8M | 3.7M | 3.7M | 3.7M | 3.6M | 3.6M |
| Gross Margin | 59.8% | 61.6% | 63.0% | 62.7% | 62.8% | 62.6% | 63.7% | 60.3% | 60.2% | 60.5% | 59.9% | 60.9% | 59.2% | 52.6% | 53.2% |
| Operating Margin | 33.4% | 37.9% | 38.5% | 125.7% | 37.6% | 44.5% | 45.9% | 41.2% | 39.0% | 39.3% | 36.6% | 36.6% | 31.3% | 35.5% | 36.4% |
| Profit Margin | 33.1% | 31.5% | 30.1% | 28.8% | 31.4% | 44.2% | 20.5% | 30.9% | 29.5% | 27.6% | 28.2% | 24.5% | 19.6% | 23.9% | 24.1% |